Editorial
 PPR & PHARMACY PROFESSION   
 Wednesday, May 15, 2019 
 Way back in January 2015, the Central government notified the Pharmacy Practice Regulations-2015 for enhancing the practice of pharmacy profession in the country. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Bridge Biotherapeutics presents positive data from phase I study of BBT-877 to treat idiopathic pulmonary fibrosis at ATS 2019 conference
17:00  [IST]Bayer, Nutreco ink R&D pact to develop new technologies & applications for animal health and nutrition industries
16:00  [IST]PTC Therapeutics announces winners of its PRIORITY programme to support research projects in rare, genetic disorders
15:00  [IST]Dale Medical launches new Hold-n-Place Catheter Securement devices
14:10  [IST]Torrent Pharma net loss at Rs.152 crore in Q4, dividend of 80%
14:00  [IST]T3D Therapeutics' PIONEER study of T3D-959 to treat Alzheimer's disease receives NIH grants
more news >>
TOP NEWS
08:00  [IST]US targeting to malign the image of Indian pharma industry: Pharmexcil DG
08:00  [IST]WHO issues draft guidance on environmental aspects of GMP to stall AMR
08:00  [IST]ICMR issues consensus document for management of hepatocellular carcinoma
08:00  [IST]CII, AMTZ join hands to help usher in business opportunities for MSMEs towards indigenous manufacturing
08:00  [IST]Govt should pass laws to address unfair prices of new, patented and branded drugs: Experts
08:00  [IST]DCGI warns of stern action against cos which change contents of formulations without changing existing brand names
more news >>
YESTERDAY'S NEWS
18:00  [IST]NIH funded study shows early weight-loss surgery may improve type 2 diabetes, blood pressure outcomes
17:10  [IST]GlaxoSmithKline Pharma sales remain flat, net up by 16.6% in Q4
17:00  [IST]EMA committee recommends to restrict doctors not to prescribe Xeljanz 10 mg in patients who are at high risk of blood clots in lungs
16:40  [IST]Jubilant Life Sciences inures net loss of Rs. 101 cr in Q4, dividend of 450%
16:00  [IST]RegeneRx partner, GtreeBNT receives US patent for new ophthalmic formulation of thymosin Beta 4
15:00  [IST]US FDA warns patients & healthcare professionals against use of unauthorized devices for diabetes management
more news >>
INTERVIEW  
Advanced flooring, integral part of pharma & healthcare infrastructure
Agradeep Mondal, Director Sales, Interface South Asia115398Agradeep
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
CP: HI_Korea_2019_150x60
IPJ_2019_pharmabiz_150x60
Ipe_2019_150x 60
CPhI_Korea_2019_150x60
PharmaLytica150x60_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |